Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.130, sa.02, ss.125-133, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 130 Sayı: 02
- Basım Tarihi: 2022
- Doi Numarası: 10.1055/a-1523-7216
- Dergi Adı: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.125-133
- Anahtar Kelimeler: FGFR-4, Ki-67, pituitary adenomas, tumor aggressiveness, NIGHT SALIVARY CORTISOL, CELL-ADHESION, CLASSIFICATION, ISOFORM, SOCIETY, KI-67, PROLIFERATION, RECURRENCE, FGFR4, P53
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet
Özet
Purpose To investigate the relationship of Fibroblast Growth Factor Receptor-4 (FGFR-4) expression with radiologic, pathologic, and clinical parameters in pituitary adenomas.